FIRE1 Secures $120 Million for Heart Failure Innovation

Deal News | Jan 07, 2025 | Enterprise Ireland

FIRE1, a connected medical device company, has successfully secured $120 million in financing to advance their innovative heart failure care solutions, particularly focusing on their Norm™ system. This financing, supported by key investor Enterprise Ireland, comes concurrently with the U.S. FDA awarding the Breakthrough Device Designation to the Norm™ system, underscoring its potential impact in the healthcare sector. As a recognized leader in connected medical device solutions, FIRE1 aims to utilize this financing to enhance and scale their heart failure care technologies, aiming for a significant improvement in patient management and treatment outcomes.

Sectors

  • Medical Devices
  • Healthcare Technology
  • Private Equity

Geography

  • Ireland – Enterprise Ireland is a significant investor in the reported financing, indicating the article's relevance to the Irish investment landscape.
  • United States – The FDA's involvement in awarding the Breakthrough Device Designation suggests a geographical link to the United States healthcare regulatory environment.

Industry

  • Medical Devices – The article involves FIRE1, a company that specializes in connected medical device solutions, which plays a key role in healthcare innovation.
  • Healthcare Technology – FIRE1's focus on heart failure care and the development of new healthcare solutions aligns with the Healthcare Technology sector.
  • Private Equity – Enterprise Ireland's role as an investor in FIRE1 connects the article to the Private Equity industry, highlighting financing activities in the sector.

Financials

  • $120 million – The financing amount secured by FIRE1 to advance their heart failure care solutions.

Participants

NameRoleTypeDescription
FIRE1Target CompanyCompanyA leading connected medical device solutions company specializing in heart failure care.
Enterprise IrelandInvestorCompanyA governmental organization that supports Irish businesses and innovation through funding and investment.
FDARegulatory AuthorityGovernmentThe United States Food and Drug Administration responsible for regulating medical devices, including awarding Breakthrough Device Designations.